Matthew Jenusaitis
CIK: 0001357864
Transaction Breakdown
Open Market Buys (P)1 (33.3%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NVNO
enVVeno Medical Corp
Director
Discretionary Trading P&L
Holdings
About Jenusaitis Matthew
Jenusaitis Matthew (SEC CIK 0001357864) files insider reports with the SEC as Director of enVVeno Medical Corp (NVNO).
Signal8 holds 3 ownership filings by Jenusaitis Matthew, all Form 4s, filed between Dec 20, 2024 and Dec 15, 2025. Those filings report 3 transactions, from Dec 18, 2024 to Dec 11, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Jenusaitis Matthew's filings is in IRVINE, CA.
Recent filings by Jenusaitis Matthew
Other insiders filing for enVVeno Medical Corp (NVNO)
- Duhay Francis, Director
- BERMAN ROBERT ANDREW, Chief Executive Officer
- Alavi Hamed, Chief Technology Officer
- Glickman Marc H., SVP & Chief Medical Officer
- Gray Robert, Director
- Shrivastava Sanjay, Director